Integrum establishes Center of Excellence in Ukraine

2023-12-20
MÖLNDAL, Sweden , Dec. 20, 2023 /PRNewswire/ --
Integrum (publ) (Nasdaq First North Growth Market: INTEG B) today announces that the company has established a Center of Excellence at the Center for Complex Endoprosthetics, Osseointegration and Bionics in Kyiv, with the intention to spearhead orthopedic treatment using OPRA™ Implant System in individuals who have suffered limb loss.
The need for amputee care in Ukraine has increased rapidly since the Russian invasion. More than 20,000 individuals have lost extremities, which has put a high strain on the healthcare system and created a significant need for swift actions on an infrastructure level. The new Center of Excellence is operational following recent visits to Ukraine by Dr. Brånemark. Two senior surgeons have already been trained and certified to perform both transfemoral and transhumeral surgeries using Integrum's innovative OPRA™ Implant System.
More than 10 patients have already been treated using Integrum's implant system. This was initially done as a pro bono initiative by Dr. Brånemark and Integrum but is now also part of Integrum's commercial operations.
"Following our recent efforts in Ukraine, we have had constructive conversations with resourceful partners working tirelessly to restore war victims' health. We are proud to take part in the establishment of the Center of Excellence in Kyiv, which will function both as a medical center for the clinical care of patients who have suffered limb loss and as a beacon of knowledge for surgeons to learn how to perform reconstructive surgery using the OPRA™ Implant System," says Rickard Brånemark, CEO of Integrum.
For more information, please contact:
Rickard Brånemark, CEO
Phone: +46 (0) 70 846 10 61
E-mail: [email protected]
Jörgen Svanström, CFO
Phone: + 46 (0) 70 734 96 60
E-mail: [email protected]
Certified Adviser
Carnegie Investment Bank AB (publ) is Certified Adviser
The following files are available for download:
SOURCE Integrum AB
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。